Physician identification of opioid diversion: A difficult diagnosis

Journal of Opioid Management

Volumn 8, Issue 1, 2012, Pages 5-6

  Reisfield, Gary M ^a   Sloan, Paul A ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; HYDROCODONE; OPIATE; OXYCODONE;

BEHAVIOR CHANGE; CHRONIC PAIN; CLINICAL DECISION MAKING; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DOCTOR PATIENT RELATION; DRUG ABUSE; DRUG URINE LEVEL; EDITORIAL; HUMAN; OPIATE ADDICTION; OPIOID DIVERSION; PRESCRIPTION; RISK ASSESSMENT;

ANALGESICS, OPIOID; CHRONIC PAIN; HUMANS; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 84859043054     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2012.0090     Document Type: Editorial

References (10)

1. Sloan PA: Oxymorphone in the management of pain. Ther Clin Risk Manage. 2008; 4: 1-11.
2. U.S. Prescription drug sales grow slowly; hydrocodone most prescribed. IMS Health. 2009. Available at www.seekingalpha.com/article/128003-u-s- prescription-drug-sales-grow-slowly-hydrocodone-most-prescrihed. Accessed January 3, 2012.
3. Substance Abuse and Mental Health Services Administration: Results from the 2008 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434. Rockville, MD, 2009.
4. Laws of Florida. Chapter 2011-141. Committee Substitute for House Bill No. 7095. Available at http://laws.flrules.org/2011/141. Accessed January 10, 2012.
5. Volkow ND, McLellan TA: Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011; 305(13): 1346-1347.
6. Christo PJ, Manchikanti L, Ruan X, Bottros M, Hansen H, Solanki DR, et al. Urine drug testing in chronic pain. Pain Physician. 2011; 14(2): 123-143.
7. Von Seggern RL, Fitzgerald CP, Adelman LC, et al.: Laboratory monitoring of OxyContin (oxycodone): clinical pitfalls. Headache. 2004; 44(1): 44-47. (Pubitemid 38116661)
8. Reisfield GM, Goldberger BA, Bertholf RL: "False-positive" and "false-negative" test results in clinical urine drug testing. Bioanalysis. 2009; 1(5): 937-952.
9. Reisfield GM, Webb FJ, Bertholf RL, et al.: Family physicians' proficiency inurine drug test interpretation. J Opioid Manag. 2007; 3(6): 333-337. (Pubitemid 351166545)
10. Reisfield GM, Bertholf R, Barkin RL, et al.: Urine drug test interpretation: what do physicians know? J Opioid Manag. 2007; 3(2): 80-86.